EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry

Imelda G Peña, Honeymae C Alos, Nicole Kaye R Calara, Hilary Grace C Pavia, Bryan Paul I Bulatao

Acta Medica Philippina · 12.05.2026

DOI: 10.47895/amp.vi0.13435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Medica Philippina, online erschienen am 12.05.2026. Verfasst von Imelda G Peña und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, National Institutes of Health, University of the Philippines Manila. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study aimed to identify problems and highlight opportunities for pharmaceutical sciences research in the Philippine pharmaceutical industry's regulatory and clinical research sectors that might have been previously overlooked or underrepresented. It identified current issues that can be addressed by research covering four areas of pharmaceutical sciences: drug design and discovery, pharmacokinetic/pharmacodynamic studies, formulation design and pharmaceutical technology, and regulatory science.

Methods

A descriptive qualitative approach was used in this study. Data collection was facilitated by key informant interviews (KII) using a standardized interview guide with open-ended questions to identify the pharmaceutical science research needs of the specific sectors. A purposive sampling method was employed, with five key informants (KIs), including the company vice president, director, and top-level managers from different local and multinational pharmaceutical companies. ATLAS.ti software was utilized to facilitate thematic synthesis for qualitative data analysis.

Results

Thirteen common themes were identified from the KIs, such as (1) incomplete development of therapeutic compounds, (2) sustainability of raw materials supply, (3) regulation of herbal medicines versus food supplements, (4) mapping disease priorities through the Philippine pharmaceutical roadmap, (5) government incentives and policies to support research, (6) technical personnel, (7) suboptimal regulatory process, approvals, and implementation, (8) gap in utilization of acquired knowledge on regulations, (9) regulatory governance, (10) passive regulatory action on counterfeit drugs, (11) PIC/S GMP version 14 adaption, (12) formulation optimization, and (13) active pharmaceutical ingredient (API) sourcing and regulation. Based on insights from the International Pharmaceutical Federation regarding anticipated hurdles in pharmaceutical sciences over the next 5-10 years, priority research needs were identified through KIs' input. Relevant action plans were developed, including the creation of research proposals to isolate, purify, and determine chemical structures of natural products, as well as analyzing recent Philippine Health Statistics to help assess the appropriateness of new drug releases for patient needs. Other action plans include forecasting future disease burdens in the country, performing toxicology studies (Health-Based Evaluation Levels/No Observed Adverse Effect Level or HBEL/NOAEL) for common generic drugs, and ensuring that research efforts are directed toward addressing the Philippine pharmaceutical regulatory and clinical research sector's most pressing needs practically and feasibly.

Conclusion

This study offers valuable insights into pharmaceutical sciences research and development initiatives within the regulatory and clinical research sectors in the Philippine pharmaceutical industry. These findings have the potential to catalyze transformative advancements in healthcare delivery and outcomes, positioning the Philippines for global excellence and competitiveness.

Schlagwörter

Stichwörter der Autor:innen

drug approvalhealth policypharmaceutical sciencesqualitative researchthematic analysis

Autor:innen und Institutionen

  • Institute of Pharmaceutical Sciences, National Institutes of Health, University of the Philippines Manila.
  • Department of Clinical, Social and Administrative Pharmacy, College of Pharmacy, University of the Philippines Manila.
  • Department of Industrial Pharmacy, College of Pharmacy, University of the Philippines Manila.

Zitieren

APA

Peña, I. G., Alos, H. C., Calara, N. K. R., Pavia, H. G. C., & Bulatao, B. P. I. (2026). Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry. Acta Medica Philippina. https://doi.org/10.47895/amp.vi0.13435

Vancouver

Peña IG, Alos HC, Calara NKR, Pavia HGC, Bulatao BPI. Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry. Acta Medica Philippina. 2026. doi:10.47895/amp.vi0.13435

BibTeX
@article{Pea2026,
  author = {Peña, Imelda G and Alos, Honeymae C and Calara, Nicole Kaye R and Pavia, Hilary Grace C and Bulatao, Bryan Paul I},
  title = {Research Needs in Philippine Pharmaceutical Sciences: A Qualitative Perspective from Regulatory and Clinical Research Sectors of the Pharmaceutical Industry},
  journal = {Acta Medica Philippina},
  year = {2026},
  doi = {10.47895/amp.vi0.13435}
}
Kostenlos starten →